Alexion Pharma (ALXN) Announces Restructuring, Including Workforce Reduction of 20%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/10/2026
- S&P 500, Nasdaq futures tick higher with Hormuz outlook in focus
- Oil edges higher as Iran tempers hopes of swift Hormuz reopening
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Atlassian results seen as 'game changer' for AI kills software worries
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Alexion Announces Restructuring to Advance Corporate Strategy
September 12, 2017 8:00 AM EDTExpect to Deliver Approximately $270 Million in GAAP and Approximately $250 Million in Non-GAAP Pre-tax Savings Annually by 2019 Global Workforce Reduction of Approximately 20% Expect to Reinvest Approximately $100 Million Annually to Build Pipeline Through Disciplined Business Development and Additional Complement Indications Maximize Leadership in Complement and Grow Rare Disease Business by Focusing Investments in Priority Growth Areas Research Center of Excellence to be Based in New Haven, CT New Headquarters in Boston, MA to Support Innovation and Future Growth... More
Alexion to Host Call to Discuss Restructuring to Advance Corporate Strategy at 8:30 a.m. on September 12, 2017
September 11, 2017 4:15 PM EDTNEW HAVEN, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that the Company will issue a press release on its restructuring to advance its corporate strategy on Tuesday, September 12, 2017 at 8:00 a.m. ET. Following the release, Alexion management will conduct a... More
